BridgeBio Oncology Therapeutics is a clinical-stage biopharmaceutical company developing next-generation small molecule therapeutics targeting RAS and PI3Kα malignancies, which are prevalent oncogenes in human tumors.
Bridgebio Oncology Therapeutics stock last closed at $8.94, down 5.4% from the previous day, and has decreased 13.29% in one year. It has overperformed other stocks in the Biotechnology industry by 0.4 percentage points. Bridgebio Oncology Therapeutics stock is currently +5.18% from its 52-week low of $8.50, and -28.48% from its 52-week high of $12.50.
There are currently 61.1M BBOT shares outstanding. The market cap of BBOT is $546.23M. In the past 24 hours, 244,000 BBOT shares were traded.
How to Buy Bridgebio Oncology Therapeutics Stock
Wondering how to invest in Bridgebio Oncology Therapeutics stock? Here's how.
Choose where to buy Bridgebio Oncology Therapeutics stock: You need to pick an online brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you choose where to buy Bridgebio Oncology Therapeutics stock.
Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
Fund your brokerage account: Pick your payment method and add your details.
Research Bridgebio Oncology Therapeutics stock: The Bridgebio Oncology Therapeutics ticker symbol is BBOT. Is Bridgebio Oncology Therapeutics stock a good investment? Should you buy shares of BBOT? How do BBOT's underlying business fundamentals look? Do top analysts think Bridgebio Oncology Therapeutics is a good buy? Why has BBOT's stock price moved recently? (Hint: Our stock research tools can help you decide if BBOT is a good stock to buy).
Place your BBOT purchase: Decide if you will purchase BBOT shares at the current market price or use a limit order to purchase BBOT shares at a given price.
Get the latest news on your investment in BBOT: Create a watchlist to get live updates on your new investment in Bridgebio Oncology Therapeutics shares.
Step 1: Choose where to buy Bridgebio Oncology Therapeutics stock
You need an online brokerage account to access the NASDAQ market and buy BBOT shares.
A brokerage account allows you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our experience, eToro is the best stock brokerage. eToro gives you:
You can invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to world financial markets: From Technology to Financial Services, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by creating an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create a brokerage account
Now that you've picked your brokerage, the next step is to fill out some personal info so you can buy BBOT stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Bridgebio Oncology Therapeutics stock
After you have selected the best place to buy Bridgebio Oncology Therapeutics stock, it's absolutely critical to evaluate their stock prior to investing, so you can understand the risk and opportunity.
Bridgebio Oncology Therapeutics Numbers
BBOT Price
$8.94
1w %
1.13%
1y %
-13.29%
5y %
N/A
P/E
-0.02x
P/B
-2.4x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$106.51M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$546.23M
Next Earnings
Sep 3, 2025
Next Dividend
N/A
Bridgebio Oncology Therapeutics Due Diligence Checks
WallStreetZen was created to help part-time investors perform more in-depth fundamental analysis quickly.
No, Bridgebio Oncology Therapeutics doesn't provide an income stream by paying out dividends.
What others are saying about BBOT
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Place your BBOT purchase
There are two main types of orders:
Market order: A market order is an order to buy or sell a stock at the best possible price. Market orders are usually fine.
Limit order: A limit order allows you to buy or sell a stock at a specific price (or better). If you want to be sure you're buying or selling at a given price, place a limit order.
Click the Open button and eToro will execute the order.
If you want additional assistance buying stocks on eToro, watch the helpful video below:
How much does it cost to buy one Bridgebio Oncology Therapeutics share?
As of Aug 29, 2025, it costs $8.94 to buy one share of Bridgebio Oncology Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $4, you can buy 0.447 shares of BBOT.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.